These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25162152)

  • 21. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study.
    Sato S; Shimizu Y; Goto T; Kitahara A; Koike T; Ishikawa H; Watanabe T; Tsuchida M
    BMC Pulm Med; 2018 Aug; 18(1):134. PubMed ID: 30097033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.
    Harari S; Davì M; Biffi A; Caminati A; Ghirardini A; Lovato V; Cricelli C; Lapi F
    Intern Emerg Med; 2020 Apr; 15(3):437-445. PubMed ID: 31541394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rising incidence of idiopathic pulmonary fibrosis in the U.K.
    Navaratnam V; Fleming KM; West J; Smith CJ; Jenkins RG; Fogarty A; Hubbard RB
    Thorax; 2011 Jun; 66(6):462-7. PubMed ID: 21525528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
    [No Abstract]   [Full Text] [Related]  

  • 25. Idiopathic pulmonary fibrosis in East Asian.
    Sun C; Sun Y; Shen H; Yang C; Xu S
    Intractable Rare Dis Res; 2017 May; 6(2):80-86. PubMed ID: 28580206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
    Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
    Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of Idiopathic Pulmonary Fibrosis among U.S. Veterans, 2010-2019.
    Kaul B; Lee JS; Zhang N; Vittinghoff E; Sarmiento K; Collard HR; Whooley MA
    Ann Am Thorac Soc; 2022 Feb; 19(2):196-203. PubMed ID: 34314645
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
    Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
    Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
    Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
    Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
    Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
    Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
    Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
    Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
    Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis.
    Abe S; Azuma A; Mukae H; Ogura T; Taniguchi H; Bando M; Sugiyama Y
    Intern Med; 2012; 51(12):1487-91. PubMed ID: 22728479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
    Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K
    BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis.
    Nishimoto K; Fujisawa T; Yoshimura K; Enomoto Y; Enomoto N; Nakamura Y; Inui N; Sumikawa H; Johkoh T; Colby TV; Suda T
    Respirology; 2018 May; 23(5):519-525. PubMed ID: 29130562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.
    Ley B; Urbania T; Husson G; Vittinghoff E; Brush DR; Eisner MD; Iribarren C; Collard HR
    Ann Am Thorac Soc; 2017 Jun; 14(6):880-887. PubMed ID: 28355518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.